Amornrat Romphruk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amornrat Romphruk has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
C. Leelayuwat
Department of Clinical Immunology and Transfusion Sciences, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
11 shared publicationsC Puapairoj
8 shared publicationsC. Puapairoj
Blood Transfusion Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
7 shared publications- Chanvit Leelayuwat
Centre for Research and Development of Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
7 shared publications Y Urwijitaroon
Blood Transfusion Centre, Faculty of Medicine, Khon Kaen University, Thailand
6 shared publications- Jerzy Kazimierz Kulski
School of Biomedical Science, Discipline of Microbiology and Immunology, The University of Western Australia, Crawley, WA 6009, Australia
5 shared publications
Latest Publications
- 5 May 2021
- Published by Wiley in Transfusion Medicine
- Vol. 31 (3) , 186-192
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors
Objectives: In our study group of Thai PLT apheresis donors, we assessed the prevalence of anti‐leucocyte antibodies.Background: Antibodies against human leucocyte antigens (anti‐HLA), neutrophil antigens (anti‐HNA), and major histocompatibility complex class I related chain A (anti‐MICA) in blood products can lead to transfusion‐related acute lung injury (TRALI). To reduce the risk of TRALI, some blood centres are implementing strategies based on screening platelet (PLT) apheresis donors for the presence of anti‐leucocyte antibodies.Methods/Materials: Blood samples were collected from non‐transfused individuals, 340 males and 63 females (50 nulliparous and 13 parous). Anti‐HLA class I and II and anti‐MICA were analysed using the Luminex assay, and anti‐HNA‐3 was detected using the granulocyte agglutination test.Results: Anti‐HLA was found in 14 of 403 subjects (3.5%). Ten subjects (2.5%) tested positive for HLA class I, 2 (0.5%) for HLA class II, and 2 (0.5%) for both HLA class I and HLA class II. Anti‐HLA class I or II were detected in 2 of 13 (15.4%) parous females and only anti‐HLA class I was found in 4 (8.0%) nulliparous females. Six of 327 subjects tested (1.8%), all males, were positive for anti‐MICA. Anti‐HNA‐3 was not found in any of the 403 individuals.Conclusions: Screening for anti‐HLA class I and II should be implemented for Thai PLT apheresis donors. Although immunisation against HNA and MICA seems to be a rare event in Thais, further work is necessary to decide whether our PLT apheresis donors should be screened for HNA and MICA antibodies.
- 5 May 2021
- Published by Wiley in Transfusion Medicine
- Vol. 31 (3) , 186-192
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors
Objectives: In our study group of Thai PLT apheresis donors, we assessed the prevalence of anti‐leucocyte antibodies.Background: Antibodies against human leucocyte antigens (anti‐HLA), neutrophil antigens (anti‐HNA), and major histocompatibility complex class I related chain A (anti‐MICA) in blood products can lead to transfusion‐related acute lung injury (TRALI). To reduce the risk of TRALI, some blood centres are implementing strategies based on screening platelet (PLT) apheresis donors for the presence of anti‐leucocyte antibodies.Methods/Materials: Blood samples were collected from non‐transfused individuals, 340 males and 63 females (50 nulliparous and 13 parous). Anti‐HLA class I and II and anti‐MICA were analysed using the Luminex assay, and anti‐HNA‐3 was detected using the granulocyte agglutination test.Results: Anti‐HLA was found in 14 of 403 subjects (3.5%). Ten subjects (2.5%) tested positive for HLA class I, 2 (0.5%) for HLA class II, and 2 (0.5%) for both HLA class I and HLA class II. Anti‐HLA class I or II were detected in 2 of 13 (15.4%) parous females and only anti‐HLA class I was found in 4 (8.0%) nulliparous females. Six of 327 subjects tested (1.8%), all males, were positive for anti‐MICA. Anti‐HNA‐3 was not found in any of the 403 individuals.Conclusions: Screening for anti‐HLA class I and II should be implemented for Thai PLT apheresis donors. Although immunisation against HNA and MICA seems to be a rare event in Thais, further work is necessary to decide whether our PLT apheresis donors should be screened for HNA and MICA antibodies.
- 4 March 2020
- Published by Wiley in Transfusion
- Vol. 60 (4) , 847-854
Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma
BACKGROUND: Anti‐CD36s, developing after transfusion or during pregnancy, play an important role in immune‐mediated bleeding disorders among Asian populations. Currently, little is known about the clinical relevance of anti‐CD36. Here, we aimed to determine the frequency of CD36 deficiency in Thais by analyzing CD36 expression on cell surfaces and in plasma.STUDY DESIGN AND METHODS: The expression and deficiency of CD36 on platelets and monocytes were determined by flow cytometry. Mutations in the CD36 gene were analyzed by nucleotide sequencing. Soluble CD36 (sCD36) in plasma was quantified with enzyme‐linked immunosorbent assay.RESULTS: Fifteen of 700 blood donors (2.14%) were identified as CD36 deficient. The frequencies of Type I and II CD36 deficiency were 0.43% and 1.71%, respectively. Type I individuals exhibited c.1163A > T, c.429 + 4insG, and c.1156C > T. Type II individuals exhibited c.879 T > C, c.329‐330delAC, c.818 + 108delAACT, c.1125 + 13C > A, and c.1163A > T. CD36 on donor platelets (n = 685) showed a wide distribution of expression levels (mean fluorescence intensity, 16.71 ± 8.68). In the normal phenotype (n = 14), sCD36 concentration was 58.84 ± 11.68 ng/mL, which was significantly correlated with platelet CD36 expression (r2 = 0.8551). In Type II–deficient individuals (n = 6), a similar sCD36 concentration was detected (53.67 ± 8.17 ng/mL). However, sCD36 could not be detected in Type I individuals (n = 3).CONCLUSION: CD36 Type I deficiency was found, indicating the potential for immune‐mediated platelet disorders in Thais. However, the underlying mutations differed from those reported in Japan and China. Interestingly, sCD36 could not be detected in plasma of Type I–deficient individuals. This finding may lead to the use of plasma to identify individuals at risk and to allow screening of large cohorts.
- 4 March 2020
- Published by Wiley in Transfusion
- Vol. 60 (4) , 847-854
Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma
BACKGROUND: Anti‐CD36s, developing after transfusion or during pregnancy, play an important role in immune‐mediated bleeding disorders among Asian populations. Currently, little is known about the clinical relevance of anti‐CD36. Here, we aimed to determine the frequency of CD36 deficiency in Thais by analyzing CD36 expression on cell surfaces and in plasma.STUDY DESIGN AND METHODS: The expression and deficiency of CD36 on platelets and monocytes were determined by flow cytometry. Mutations in the CD36 gene were analyzed by nucleotide sequencing. Soluble CD36 (sCD36) in plasma was quantified with enzyme‐linked immunosorbent assay.RESULTS: Fifteen of 700 blood donors (2.14%) were identified as CD36 deficient. The frequencies of Type I and II CD36 deficiency were 0.43% and 1.71%, respectively. Type I individuals exhibited c.1163A > T, c.429 + 4insG, and c.1156C > T. Type II individuals exhibited c.879 T > C, c.329‐330delAC, c.818 + 108delAACT, c.1125 + 13C > A, and c.1163A > T. CD36 on donor platelets (n = 685) showed a wide distribution of expression levels (mean fluorescence intensity, 16.71 ± 8.68). In the normal phenotype (n = 14), sCD36 concentration was 58.84 ± 11.68 ng/mL, which was significantly correlated with platelet CD36 expression (r2 = 0.8551). In Type II–deficient individuals (n = 6), a similar sCD36 concentration was detected (53.67 ± 8.17 ng/mL). However, sCD36 could not be detected in Type I individuals (n = 3).CONCLUSION: CD36 Type I deficiency was found, indicating the potential for immune‐mediated platelet disorders in Thais. However, the underlying mutations differed from those reported in Japan and China. Interestingly, sCD36 could not be detected in plasma of Type I–deficient individuals. This finding may lead to the use of plasma to identify individuals at risk and to allow screening of large cohorts.
- 18 March 2019
- Published by Wiley in International Journal of Immunogenetics
- Vol. 46 (3) , 160-165
Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd blood group systems among ethnic Thai blood donors from the north‐east of Thailand
We here report the first study of antigen and phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd antigens in north‐east Thai blood donors. Blood transfusion services aim to ensure availability of adequate and safe blood to minimize the development of transfusion reactions. For pre‐transfusion testing, the most important blood group systems are ABO and RhD. The transfusion of ABO‐compatible otherwise unknown phenotype blood may result in alloimmunization, especially in multi‐transfused patients. Extended red blood cell (RBC) phenotyping and selection of blood negative for specific antigens reduce post‐transfusion complications and allow for effective blood transfusion regimens to be achieved. A total of 13,567 regular repeated, voluntary Thai blood donors were included for red‐cell antigen typing of Rh (D, C, E, c, e). Samples from 12,768, 9,389 and 13,059 donors were typed for Kidd, M and Mia antigens, respectively. Amongst Rh antigens, e was the most common (96.80%) followed by C (95.50%), c (34.40%) and E (32.20%) with CCDee (60.00%) being the most common phenotype. For Kidd phenotypes, Jk(a+b+) was the most common (46.73%) and Jk(a−b−) was rare (0.07%). For the M and Mia antigen, M(+) was most frequently found (94.96%) and Mia(+) was found in 17.97% of individuals. Knowledge of red‐cell antigen phenotype frequencies in a population is helpful for creating a phenotype database of blood donors which can provide antigen‐negative compatible blood to patients with multiple alloantibodies. Moreover, provision of antigen‐matched blood can prevent alloimmunization in multi‐transfused patients.
- 18 March 2019
- Published by Wiley in International Journal of Immunogenetics
- Vol. 46 (3) , 160-165
Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd blood group systems among ethnic Thai blood donors from the north‐east of Thailand
We here report the first study of antigen and phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd antigens in north‐east Thai blood donors. Blood transfusion services aim to ensure availability of adequate and safe blood to minimize the development of transfusion reactions. For pre‐transfusion testing, the most important blood group systems are ABO and RhD. The transfusion of ABO‐compatible otherwise unknown phenotype blood may result in alloimmunization, especially in multi‐transfused patients. Extended red blood cell (RBC) phenotyping and selection of blood negative for specific antigens reduce post‐transfusion complications and allow for effective blood transfusion regimens to be achieved. A total of 13,567 regular repeated, voluntary Thai blood donors were included for red‐cell antigen typing of Rh (D, C, E, c, e). Samples from 12,768, 9,389 and 13,059 donors were typed for Kidd, M and Mia antigens, respectively. Amongst Rh antigens, e was the most common (96.80%) followed by C (95.50%), c (34.40%) and E (32.20%) with CCDee (60.00%) being the most common phenotype. For Kidd phenotypes, Jk(a+b+) was the most common (46.73%) and Jk(a−b−) was rare (0.07%). For the M and Mia antigen, M(+) was most frequently found (94.96%) and Mia(+) was found in 17.97% of individuals. Knowledge of red‐cell antigen phenotype frequencies in a population is helpful for creating a phenotype database of blood donors which can provide antigen‐negative compatible blood to patients with multiple alloantibodies. Moreover, provision of antigen‐matched blood can prevent alloimmunization in multi‐transfused patients.
- 15 November 2018
- Published by Wiley in Transfusion
- Vol. 59 (1) , 177-184
The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐matched red blood cells for thalassemia transfusions: a 10‐year experience at a tertiary care hospital
BACKGROUND: Hemoglobin E‐β0 thalassemia and homozygous β0‐thalassemia are the most common chronic transfusion‐dependent thalassemias in Thailand. Patients with these conditions can experience clinical complications such as RBC alloimmunization. In this study we aimed to determine the prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐ (C, c, E, e, Mia) matched RBC transfusion.STUDY DESIGN AND METHODS: Thalassemia patients were recruited from a tertiary care hospital for 10 years from 2008 to 2017. The medical records of transfusion history were reviewed for red cell phenotype both of patients and donors, number of units transfused, and type of alloantibodies.RESULTS: A total of 383 thalassemia patients were identified (178 males and 205 females). The frequency of RBC alloantibodies was 19.3%. Some patients tested positive for more than one antibody type. Autoantibodies were detected in nine individuals. Anti‐E (49 [39.5%]), anti‐Mia (24 [19.4%]), and anti‐c (19 [15.3%]) were the most common antibodies detected. A high rate of alloimmunization was found in splenectomized patients. Risk of alloimmunization increased when more total units of blood had been transfused. A trend toward low alloimmunization rates was noted in the antigen‐matched RBC group, where 3.5% (5/143) of patients were alloimmunized. Anti‐E and anti‐Mia, which may be naturally occurring, were identified in this group.CONCLUSION: Thai patients are more prone to develop antibodies against the Rh and Mia than to the Kell blood group antigens. Provision of at least antigen‐matched (C, c, E, e, Mia) RBCs appears to improve the efficacy of transfusion in thalassemia patients.
- 15 November 2018
- Published by Wiley in Transfusion
- Vol. 59 (1) , 177-184
The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐matched red blood cells for thalassemia transfusions: a 10‐year experience at a tertiary care hospital
BACKGROUND: Hemoglobin E‐β0 thalassemia and homozygous β0‐thalassemia are the most common chronic transfusion‐dependent thalassemias in Thailand. Patients with these conditions can experience clinical complications such as RBC alloimmunization. In this study we aimed to determine the prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen‐ (C, c, E, e, Mia) matched RBC transfusion.STUDY DESIGN AND METHODS: Thalassemia patients were recruited from a tertiary care hospital for 10 years from 2008 to 2017. The medical records of transfusion history were reviewed for red cell phenotype both of patients and donors, number of units transfused, and type of alloantibodies.RESULTS: A total of 383 thalassemia patients were identified (178 males and 205 females). The frequency of RBC alloantibodies was 19.3%. Some patients tested positive for more than one antibody type. Autoantibodies were detected in nine individuals. Anti‐E (49 [39.5%]), anti‐Mia (24 [19.4%]), and anti‐c (19 [15.3%]) were the most common antibodies detected. A high rate of alloimmunization was found in splenectomized patients. Risk of alloimmunization increased when more total units of blood had been transfused. A trend toward low alloimmunization rates was noted in the antigen‐matched RBC group, where 3.5% (5/143) of patients were alloimmunized. Anti‐E and anti‐Mia, which may be naturally occurring, were identified in this group.CONCLUSION: Thai patients are more prone to develop antibodies against the Rh and Mia than to the Kell blood group antigens. Provision of at least antigen‐matched (C, c, E, e, Mia) RBCs appears to improve the efficacy of transfusion in thalassemia patients.
- 7 June 2017
- Published by Wiley in Transfusion Medicine
- Vol. 28 (1) , 47-55
Assessment of HNA alloimmunisation risk in Northeastern Thais, Burmese and Karen
SUMMARY: Objectives: This study aimed to determine human neutrophil antigen (HNA) frequency, estimate possible HNA incompatibilities and predict the risk of HNA alloimmunisation in the Northeastern Thai, Burmese and Karen populations.Background: Alloantibodies against HNA are implicated in a number of clinical conditions, including immune‐mediated neutropenia and transfusion reactions.Methods: A total of 400 unrelated healthy Thais, 261 Burmese and 249 Karen was included in this study. DNA samples were typed for HNA‐1, ‐3, ‐4 and ‐5 systems using polymerase chain reactions with sequence‐specific primers (PCR‐SSP).Results: In this cohort, HNA‐1a was more prevalent than HNA‐1b. Accordingly, the possible risk of HNA‐1a alloimmunisation against HNA‐1a is lower than HNA‐1b (0·0802–0·1351 vs 0·2293–0·2497). This is in contrast to the situation reported in Caucasian and African populations. The predicted risk of HNA‐3 incompatibility in Thais, Burmese and Karen were 28·09%, 30·66% and 22·77%, respectively. The possible risks of HNA‐3a alloimmunisation were 0·0493 in Thais, 0·0608 in Burmese and 0·0196 in Karen, respectively. No individuals were found to be homozygous for HNA‐4bb. The probability of developing alloantibodies against HNA‐4a was low in these populations and every population in Asia. In contrast, the overall frequency of HNA‐5bb homozygous individuals was high in this study, peaking at 0·192.Conclusions: This is the first study that reported the allele frequencies of HNA‐1, ‐3, ‐4, and ‐5 in a large sample of healthy unrelated individuals from ethnic Thais, Burmese and Karen. Our results indicated the high possible risk of HNA‐1, ‐3 and ‐5 alloimmunisation in these populations.
- 7 June 2017
- Published by Wiley in Transfusion Medicine
- Vol. 28 (1) , 47-55
Assessment of HNA alloimmunisation risk in Northeastern Thais, Burmese and Karen
SUMMARY: Objectives: This study aimed to determine human neutrophil antigen (HNA) frequency, estimate possible HNA incompatibilities and predict the risk of HNA alloimmunisation in the Northeastern Thai, Burmese and Karen populations.Background: Alloantibodies against HNA are implicated in a number of clinical conditions, including immune‐mediated neutropenia and transfusion reactions.Methods: A total of 400 unrelated healthy Thais, 261 Burmese and 249 Karen was included in this study. DNA samples were typed for HNA‐1, ‐3, ‐4 and ‐5 systems using polymerase chain reactions with sequence‐specific primers (PCR‐SSP).Results: In this cohort, HNA‐1a was more prevalent than HNA‐1b. Accordingly, the possible risk of HNA‐1a alloimmunisation against HNA‐1a is lower than HNA‐1b (0·0802–0·1351 vs 0·2293–0·2497). This is in contrast to the situation reported in Caucasian and African populations. The predicted risk of HNA‐3 incompatibility in Thais, Burmese and Karen were 28·09%, 30·66% and 22·77%, respectively. The possible risks of HNA‐3a alloimmunisation were 0·0493 in Thais, 0·0608 in Burmese and 0·0196 in Karen, respectively. No individuals were found to be homozygous for HNA‐4bb. The probability of developing alloantibodies against HNA‐4a was low in these populations and every population in Asia. In contrast, the overall frequency of HNA‐5bb homozygous individuals was high in this study, peaking at 0·192.Conclusions: This is the first study that reported the allele frequencies of HNA‐1, ‐3, ‐4, and ‐5 in a large sample of healthy unrelated individuals from ethnic Thais, Burmese and Karen. Our results indicated the high possible risk of HNA‐1, ‐3 and ‐5 alloimmunisation in these populations.
- 3 October 2016
- Published by Wiley in Transfusion Medicine
- Vol. 27 (1) , 60-65
Human platelet antigens in Burmese, Karen and north‐eastern Thais
SUMMARY: Objectives: A comparative study of allele frequencies at HPA‐1 to ‐6 and HPA‐15 in Burmese and Karen populations as well as at HPA‐15 in north‐eastern Thais (NET) is presented.Background: Human platelet antigens (HPAs) are clinically important in several immune platelet disorders, including foetal and neonatal alloimmune thrombocytopenia (FNAIT), post‐transfusion purpura (PTP) and platelet transfusion refractoriness (PTR). The knowledge of antigen frequencies in a population is essential for the evaluation of patients suffering from immune‐mediated platelet disorders.Methods: A total of 285 unrelated, healthy Burmese, 242 Karen and 300 NET were recruited to this study. Genotype and allele frequencies of HPA‐1 to ‐6 and HPA‐15 were defined using polymerase chain reaction sequence‐specific primers (PCR‐SSP)Results: No individuals homozygous for HPA‐1bb, ‐2bb, ‐4bb, ‐5bb and ‐6bb were detected. HPA‐1a, ‐2a, ‐4a, ‐5a and ‐6a were present in all samples of Burmese and Karen origin. HPA‐1b, ‐2b, ‐4b, ‐5b and ‐6b were rare in these populations. The frequencies of HPA‐3a/‐3b were 60·4/39·6% in Burmese and 55·8/44·2% in Karen, respectively. Frequencies of HPA‐15a/‐15b were 57·2/42·8% in Burmese, 52·5/47·5% in Karen and 49·8/50·2% in NET.Conclusions: The frequencies of HPA genotypes in our study indicates that HPA‐1a, ‐2a, ‐4a, ‐5a and ‐6a are unlikely involved in FNAIT, PTP and PTR in Burmese and Karen populations. However, HPA‐1b, ‐2b, ‐3a, ‐3b, ‐4b, ‐5b, ‐6b, ‐15a and ‐15b may likely stimulate alloantibodies in these populations.
- 3 October 2016
- Published by Wiley in Transfusion Medicine
- Vol. 27 (1) , 60-65
Human platelet antigens in Burmese, Karen and north‐eastern Thais
SUMMARY: Objectives: A comparative study of allele frequencies at HPA‐1 to ‐6 and HPA‐15 in Burmese and Karen populations as well as at HPA‐15 in north‐eastern Thais (NET) is presented.Background: Human platelet antigens (HPAs) are clinically important in several immune platelet disorders, including foetal and neonatal alloimmune thrombocytopenia (FNAIT), post‐transfusion purpura (PTP) and platelet transfusion refractoriness (PTR). The knowledge of antigen frequencies in a population is essential for the evaluation of patients suffering from immune‐mediated platelet disorders.Methods: A total of 285 unrelated, healthy Burmese, 242 Karen and 300 NET were recruited to this study. Genotype and allele frequencies of HPA‐1 to ‐6 and HPA‐15 were defined using polymerase chain reaction sequence‐specific primers (PCR‐SSP)Results: No individuals homozygous for HPA‐1bb, ‐2bb, ‐4bb, ‐5bb and ‐6bb were detected. HPA‐1a, ‐2a, ‐4a, ‐5a and ‐6a were present in all samples of Burmese and Karen origin. HPA‐1b, ‐2b, ‐4b, ‐5b and ‐6b were rare in these populations. The frequencies of HPA‐3a/‐3b were 60·4/39·6% in Burmese and 55·8/44·2% in Karen, respectively. Frequencies of HPA‐15a/‐15b were 57·2/42·8% in Burmese, 52·5/47·5% in Karen and 49·8/50·2% in NET.Conclusions: The frequencies of HPA genotypes in our study indicates that HPA‐1a, ‐2a, ‐4a, ‐5a and ‐6a are unlikely involved in FNAIT, PTP and PTR in Burmese and Karen populations. However, HPA‐1b, ‐2b, ‐3a, ‐3b, ‐4b, ‐5b, ‐6b, ‐15a and ‐15b may likely stimulate alloantibodies in these populations.
- 12 August 2015
- Published by Wiley in Tissue Antigens
- Vol. 86 (3) , 199-204
HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand
This is the first report on human leukocyte antigen (HLA) allele and haplotype frequencies at three class I loci and two class II loci in unrelated healthy individuals from two ethnic groups, 170 Burmese and 200 Karen, originally from Burma (Myanmar), but sampled while residing in Thailand. Overall, the HLA allele and haplotype frequencies detected by polymerase chain reaction sequence-specific primer (PCR-SSP) at five loci (A, B, C, DRB1 and DRQB1) at low resolution showed distinct differences between the Burmese and Karen. In Burmese, five HLA-B*15 haplotypes with different HLA-A and HLA-DR/DQ combinations were detected with three of these not previously reported in other Asian populations. The data are important in the fields of anthropology, transplantation and disease-association studies.
- 12 August 2015
- Published by Wiley in Tissue Antigens
- Vol. 86 (3) , 199-204
HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand
This is the first report on human leukocyte antigen (HLA) allele and haplotype frequencies at three class I loci and two class II loci in unrelated healthy individuals from two ethnic groups, 170 Burmese and 200 Karen, originally from Burma (Myanmar), but sampled while residing in Thailand. Overall, the HLA allele and haplotype frequencies detected by polymerase chain reaction sequence-specific primer (PCR-SSP) at five loci (A, B, C, DRB1 and DRQB1) at low resolution showed distinct differences between the Burmese and Karen. In Burmese, five HLA-B*15 haplotypes with different HLA-A and HLA-DR/DQ combinations were detected with three of these not previously reported in other Asian populations. The data are important in the fields of anthropology, transplantation and disease-association studies.
- 1 August 2013
- Published by Wolters Kluwer Health in Cornea
- Vol. 32 (8) , 1116-1119
Contamination Risk of 100% Autologous Serum Eye Drops in Management of Ocular Surface Diseases
Purpose: To evaluate the sterility and safety of 100% nonpreserved, autologous, serum eye drop treatment in patients with ocular surface diseases. Methods: A total of 147 autologous serum bottles (294 samples) from 21 patients with ocular surface diseases were included. Seven bottles with autologous serum were prepared for each patient, and each bottle was used for only 1 day, then discarded. Two samples from each bottle were taken (before use and after 24 hours of use) and then cultured in standard media. The culture plates were held for at least 6 weeks or until no growth could be confirmed. To monitor safety, all patients were admitted and evaluated for the occurrence of infection. Results: In the pretreatment group, 4 samples from 4 patients (1.36%) were positive for bacteria and 7 samples from 7 patients (2.38%) were positive for fungi. In the 24-hour-after-treatment group, 1 culture (0.34%) was positive for bacteria, and 6 samples (2.04%) from 6 patients were positive for fungi. Aspergillus spp and Fonsecaea spp were the most common organisms identified in any of the cultures. Neither clinical nor microbiological evidence of infection was demonstrated in any patient during the treatment or follow-up periods. Conclusions: Although no ocular surface infection was observed, the patients under 100% autologous serum eye drops therapy should be closely monitored for clinical evidence of fungal and bacterial infections.
- 1 August 2013
- Published by Wolters Kluwer Health in Cornea
- Vol. 32 (8) , 1116-1119
Contamination Risk of 100% Autologous Serum Eye Drops in Management of Ocular Surface Diseases
Purpose: To evaluate the sterility and safety of 100% nonpreserved, autologous, serum eye drop treatment in patients with ocular surface diseases. Methods: A total of 147 autologous serum bottles (294 samples) from 21 patients with ocular surface diseases were included. Seven bottles with autologous serum were prepared for each patient, and each bottle was used for only 1 day, then discarded. Two samples from each bottle were taken (before use and after 24 hours of use) and then cultured in standard media. The culture plates were held for at least 6 weeks or until no growth could be confirmed. To monitor safety, all patients were admitted and evaluated for the occurrence of infection. Results: In the pretreatment group, 4 samples from 4 patients (1.36%) were positive for bacteria and 7 samples from 7 patients (2.38%) were positive for fungi. In the 24-hour-after-treatment group, 1 culture (0.34%) was positive for bacteria, and 6 samples (2.04%) from 6 patients were positive for fungi. Aspergillus spp and Fonsecaea spp were the most common organisms identified in any of the cultures. Neither clinical nor microbiological evidence of infection was demonstrated in any patient during the treatment or follow-up periods. Conclusions: Although no ocular surface infection was observed, the patients under 100% autologous serum eye drops therapy should be closely monitored for clinical evidence of fungal and bacterial infections.
- 29 June 2013
- Published by Springer Nature in Immunogenetics
- Vol. 65 (9) , 645-653
Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais
Killer cell immunoglobulin-like receptors (KIRs) are cell surface receptors on natural killer (NK) cells and subsets of T cells. The functions of NK cells are partly regulated by interactions between KIRs and HLA ligands on target cells. In this study, the presence or absence of 17 KIR genes and their known HLA ligands have been investigated in 235 unrelated individuals living in northeastern Thailand (NET). Subtypes of KIR2DS4 including full length (KIR2DS4F) and deleted forms (KIR2DS4D) have also been determined. Framework genes (KIR2DL4, 3DL2, 3DL3, and 3DP1) were found in all individuals and KIR genes belonging to the A haplotype (KIR2DL1, 2DL3, 3DL1, and 2DS4) were present in more than 90 % of NET. KIR2DS4D (61.7 %) was more common than KIR2DS4F (52.8 %). A total of 33 different KIR genotypes were observed. Of these, three new genotypes were identified. The most common genotype (AA) was observed in 35.7 % of NET, and HLA-C alleles bearing the C1 epitope (HLA-C1) had the highest frequency (97 %). All individuals had at least one inhibitory KIR and its corresponding HLA ligand; 40.9 % of NET had three pairs of receptor–ligand combinations, and 18.3 % had all three receptor–ligand combinations of KIR2DL3+C1, 3DL1+Bw4, and 3DL2+A11. Surprisingly, the patterns of KIR gene frequencies in NET are more similar to those of Caucasians than Japanese, Korean, and Chinese. This is the first report on complete analysis of KIR and known HLA ligands in Thais. These data provide basic knowledge on KIR for further studies on disease associations and transplantation in northeastern Thais.
- 29 June 2013
- Published by Springer Nature in Immunogenetics
- Vol. 65 (9) , 645-653
Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais
Killer cell immunoglobulin-like receptors (KIRs) are cell surface receptors on natural killer (NK) cells and subsets of T cells. The functions of NK cells are partly regulated by interactions between KIRs and HLA ligands on target cells. In this study, the presence or absence of 17 KIR genes and their known HLA ligands have been investigated in 235 unrelated individuals living in northeastern Thailand (NET). Subtypes of KIR2DS4 including full length (KIR2DS4F) and deleted forms (KIR2DS4D) have also been determined. Framework genes (KIR2DL4, 3DL2, 3DL3, and 3DP1) were found in all individuals and KIR genes belonging to the A haplotype (KIR2DL1, 2DL3, 3DL1, and 2DS4) were present in more than 90 % of NET. KIR2DS4D (61.7 %) was more common than KIR2DS4F (52.8 %). A total of 33 different KIR genotypes were observed. Of these, three new genotypes were identified. The most common genotype (AA) was observed in 35.7 % of NET, and HLA-C alleles bearing the C1 epitope (HLA-C1) had the highest frequency (97 %). All individuals had at least one inhibitory KIR and its corresponding HLA ligand; 40.9 % of NET had three pairs of receptor–ligand combinations, and 18.3 % had all three receptor–ligand combinations of KIR2DL3+C1, 3DL1+Bw4, and 3DL2+A11. Surprisingly, the patterns of KIR gene frequencies in NET are more similar to those of Caucasians than Japanese, Korean, and Chinese. This is the first report on complete analysis of KIR and known HLA ligands in Thais. These data provide basic knowledge on KIR for further studies on disease associations and transplantation in northeastern Thais.
- 27 March 2013
- Published by Wiley in Tissue Antigens
- Vol. 81 (6) , 419-427
Development of a multiplex polymerase chain reaction‐sequence‐specific primer method for NKG2D and NKG2F single‐nucleotide polymorphism typing using isothermal multiple displacement amplification products
Natural killer group 2 member D (NKG2D) on immune effector cells recognizes multiple stress‐inducible ligands. NKG2D single‐nucleotide polymorphism (SNP) haplotypes were related to the levels of cytotoxic activity of peripheral blood mononuclear cells. Indeed, these polymorphisms were also located in NKG2F. Isothermal multiple displacement amplification (IMDA) is used for whole genome amplification (WGA) that can amplify very small genomic DNA templates into microgram with whole genome coverage. This is particularly useful in the cases of limited amount of valuable DNA samples requiring multi‐locus genotyping. In this study, we evaluated the quality and applicability of IMDA to genetic studies in terms of sensitivity, efficiency of IMDA re‐amplification and stability of IMDA products. The smallest amount of DNA to be effectively amplified by IMDA was 200 pg yielding final DNA of approximately 16 µg within 1.5 h. IMDA could be re‐amplified only once (second round of amplification), and could be kept for 5 months at 4°C and more than a year at −20°C without loosing genome coverage. The amplified products were used successfully to setup a multiplex polymerase chain reaction‐sequence‐specific primer for SNP typing of the NKG2D/F genes. The NKG2D/F multiplex polymerase chain reaction (PCR) contained six PCR mixtures for detecting 10 selected SNPs, including 8 NKG2D/F SNP haplotypes and 2 additional NKG2D coding SNPs. This typing procedure will be applicable in both clinical and research laboratories. Thus, our data provide useful information and limitations for utilization of genome‐wide amplification using IMDA and its application for multiplex NKG2D/F typing.
- 27 March 2013
- Published by Wiley in Tissue Antigens
- Vol. 81 (6) , 419-427
Development of a multiplex polymerase chain reaction‐sequence‐specific primer method for NKG2D and NKG2F single‐nucleotide polymorphism typing using isothermal multiple displacement amplification products
Natural killer group 2 member D (NKG2D) on immune effector cells recognizes multiple stress‐inducible ligands. NKG2D single‐nucleotide polymorphism (SNP) haplotypes were related to the levels of cytotoxic activity of peripheral blood mononuclear cells. Indeed, these polymorphisms were also located in NKG2F. Isothermal multiple displacement amplification (IMDA) is used for whole genome amplification (WGA) that can amplify very small genomic DNA templates into microgram with whole genome coverage. This is particularly useful in the cases of limited amount of valuable DNA samples requiring multi‐locus genotyping. In this study, we evaluated the quality and applicability of IMDA to genetic studies in terms of sensitivity, efficiency of IMDA re‐amplification and stability of IMDA products. The smallest amount of DNA to be effectively amplified by IMDA was 200 pg yielding final DNA of approximately 16 µg within 1.5 h. IMDA could be re‐amplified only once (second round of amplification), and could be kept for 5 months at 4°C and more than a year at −20°C without loosing genome coverage. The amplified products were used successfully to setup a multiplex polymerase chain reaction‐sequence‐specific primer for SNP typing of the NKG2D/F genes. The NKG2D/F multiplex polymerase chain reaction (PCR) contained six PCR mixtures for detecting 10 selected SNPs, including 8 NKG2D/F SNP haplotypes and 2 additional NKG2D coding SNPs. This typing procedure will be applicable in both clinical and research laboratories. Thus, our data provide useful information and limitations for utilization of genome‐wide amplification using IMDA and its application for multiplex NKG2D/F typing.